ATF3 and cancer: It was shown that ATF3, a Wnt/β-catenin target gene in cancer cell lines [37], can either transcriptionally repress Pdx1 expression [59] or physically interact with PDX1 to block PDX1 mediated transactivation in a murine β-cell line [60].